Haemophilus influenzae disease - Annual Epidemiological Report for 2023

Surveillance and monitoring
In 2023, 5 234 confirmed cases of invasive Haemophilus influenzae disease were reported in the EU/EEA, representing a continued increase compared to the previous year (3 983 in 2022) and a substantial rise from pandemic-era figures (1 693 in 2021, 1 838 in 2020), coinciding with the post-COVID-19 return to typical respiratory disease transmission patterns.
  • The notification rate rose to 1.2 cases per 100 000 population, the highest observed in the past five years, up from 0.9 in 2022 and 0.4 in both 2020 and 2021.
  • Age-specific rates remained highest among infants under one year of age (6.41 per 100 000 population), followed by those aged 65 years and older (3.2 per 100 000 population).
  • Serotyping data were available for 60% of cases. Among cases with known serotype, non-capsulated strains continued to dominate, accounting for 81% of infections. Serotype f was the most frequent capsulated strain, responsible for 6% (194 cases) of all cases, followed by serotype b 5% (164 cases)
  • In 2023, serotype b (Hib) represented 5% of known serotyped cases, reflecting a slight decline from 9.1% in 2022. The low proportion of serotype b (Hib) reported continues to reflect the strong effect of the Hib vaccination programmes in EU/EEA countries.
Publication file

Haemophilus influenzae disease - Annual Epidemiological Report for 2023

English (873.69 KB - PDF)

All annual epidemiological reports on Haemophilus influenzae disease

legionella AER cover 2023
Surveillance and monitoring

In 2023, the notification rate of Legionnaires’ disease increased to 3.2 cases per 100 000 population, up from the 2.6 cases per 100 000 population reported in 2022.

Legionnaires’ disease - Annual Epidemiological Report for 2023

English (1.33 MB - PDF)
aER_HAI_acquired_in_ICUs_2022_cover.png
Surveillance and monitoring

Intensive care units are the hospital wards with the highest prevalence of healthcare-associated infections (HAIs). The majority of HAIs in ICUs are associated with the use of invasive devices, and a significant proportion of these HAIs are considered preventable. Moreover

Healthcare-associated infections acquired in intensive care units - Annual Epidemiological Report for 2022

English (965.89 KB - PDF)
diph_AER_2023_Report-cover
Surveillance and monitoring

In 2023, 216 cases of diphtheria due to toxigenic Corynebacterium diphtheriae (n=155) or C. ulcerans (n=61) were reported to ECDC. The increase of diphtheria among migrants reported in several EU/EEA countries in the second half of 2022 decreased to lower levels in 2023.

Diphtheria - Annual epidemiological report 2023

English (1.09 MB - PDF)
Cover of the report: "Zoonotic influenza - Annual Epidemiological Report 2024"
Surveillance and monitoring

Nine countries reported sporadic human infections with avian influenza virus subtypes A(H5N1), A(H5N2), A(H5N6), A(H5Nx), A(H9N2), A(H10N3) for 2024.

Zoonotic influenza - Annual Epidemiological Report 2024

English (297.84 KB - PDF)
legionella AER cover
Surveillance and monitoring

In 2022, the notification rate of Legionnaires’ disease steadily increased to 2.6 per 100 000 population from the two previous years (2.4 in 2021 and 1.9 in 2020).

Legionnaires' disease - Annual Epidemiological Report for 2022

English (1.12 MB - PDF)

Share this page